martes, 5 de mayo de 2015

National Guideline Clearinghouse | Guidelines by Topic: Melanoma

National Guideline Clearinghouse | Guidelines by Topic: Melanoma

National Guideline Clearinghouse (NGC)

Guidelines by Topic

Melanoma (25)
1-20 of 25   Next >
 
1. 
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma. 2014 Oct. NGC:010571
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2. 
Adjuvant interferon for malignant melanoma. 2014 Feb. NGC:010377
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3. 
Sentinel node biopsy in primary cutaneous melanoma. 2011 Feb (revised 2014 Feb). NGC:010344
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4. 
Proton beam radiation therapy. 2013 Mar. NGC:009838
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5. 
Biopsy of a suspicious pigmented lesion. 2012 Mar (revised 2013 Feb). NGC:010248
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6. 
Management of in-transit disease of the limbs. 2010 May (revised 2013 Feb). NGC:010259
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7. 
Management of resectable stage IV primary cutaneous melanoma without nodal disease. 2010 May (revised 2013 Feb). NGC:010260
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8. 
Optimal excision margins for primary cutaneous melanoma. 2011 Feb (revised 2013 Feb). NGC:010262
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9. 
Preoperative and pretreatment investigations for malignant melanoma. 2012 Mar (revised 2013 Feb). NGC:010264
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10. 
Referral and follow-up surveillance of cutaneous melanoma. 2011 Feb (revised 2013 Feb). NGC:010266
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11. 
Systemic therapy for unresectable stage III or metastatic cutaneous melanoma. 2012 Mar (revised 2013 Feb). NGC:010269
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12. 
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma. 2012 Dec. NGC:009517
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13. 
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma. 2012 Dec. NGC:009518
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14. 
HealthPartners Dental Group and Clinics oral cancer guideline. 2007 May 2 (revised 2012 Nov 9). NGC:009498
HealthPartners Dental Group - Professional Association. View all guidelines by the developer(s)
15. 
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. 2012 Jul 9. NGC:009201
American Society of Clinical Oncology - Medical Specialty Society; Society of Surgical Oncology - Medical Specialty Society. View all guidelines by the developer(s)
16. 
Adjuvant radiation for malignant melanoma. 2012 Mar. NGC:009386
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17. 
Guidelines of care for the management of primary cutaneous melanoma. 2001 Mar (revised 2011 Nov). NGC:009038
American Academy of Dermatology - Medical Specialty Society. View all guidelines by the developer(s)
18. 
ACR Appropriateness Criteria® non-spine bone metastases. 1996 (revised 2011). [NGC Update Pending]NGC:008877
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
19. 
The role of IMRT in skin cancers. 2010 Oct 29. NGC:008831
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
20. 
Melanoma. 2010 Jun 4. NGC:008184
Finnish Medical Society Duodecim - Professional Association. View all guidelines by the developer(s)
1-20 of 25   Next >

21-25 of 25   < Previous
 
21. 
Naevi and skin cancer (basal cell and epidermoid carcinoma). 2001 Apr 30 (revised 2010 Jun 4). NGC:008186
Finnish Medical Society Duodecim - Professional Association. View all guidelines by the developer(s)
23. 
ACR–SPR practice guideline for the performance of tumor scintigraphy (with gamma cameras). 1996 (revised 2010). NGC:008421
American College of Radiology - Medical Specialty Society; Society for Pediatric Radiology - Medical Specialty Society. View all guidelines by the developer(s)
24. 
Single-agent interleukin-2 in the treatment of metastatic melanoma: a clinical practice guideline. 2006 Mar 20 (reaffirmed 2010 Aug 4). NGC:005024
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
25. 
ACR Appropriateness Criteria® single brain metastasis. 1999 (revised 2012). NGC:009678
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
21-25 of 25   < Previous

No hay comentarios:

Publicar un comentario